Our dedicated team combines world-class training from London’s leading hospitals with active involvement in cutting-edge research to provide you with comprehensive second opinions when time matters most. We understand that every patient’s situation is unique, which is why we deliver personalised, evidence-based support.
Our team brings highly specialised knowledge in breast cancer, backed by years of clinical experience in diagnosing and treating this complex disease. We understand that every patient’s case is unique, and we are dedicated to providing insights that reflect the latest advancements in oncology.
Trained at some of London’s most prestigious hospitals and renowned academic institutions, we bring a depth of expertise honed in high-volume, multidisciplinary cancer centers. Our current practice at a leading university hospital ensures that our recommendations are informed by cutting-edge protocols and diverse patient experiences.
Active involvement in clinical trials, translational research, and medical education keeps our recommendations aligned with the most current, evidence-based standards of care. By regularly participating in top national and international breast cancer conferences, we ensure that our insights incorporate the latest breakthroughs in treatment and diagnostics.
We know that time is critical in cancer care. That is why we prioritise swift, thorough evaluations, delivering expert second opinions without unnecessary delays. Our goal is to provide clarity and confidence when making important treatment decisions.
Beyond medical expertise, we are committed to offering clear, compassionate guidance tailored to your individual needs. Whether you seek reassurance about your diagnosis, a deeper understanding of treatment options (including endocrine therapy, chemotherapy, immunotherapy or targeted treatments), or insights into clinical trials, we empower you with the knowledge to make informed choices.
A second opinion can bring peace of mind, open new treatment possibilities, or confirm the best path forward. Let us help you navigate your journey with expertise, care and unwavering support.
Dr Elsa Papadimitraki is a Medical Oncology Consultant at University College London Hospital (UCLH), where she serves in the Breast Unit and Early Phase Trials Unit. Renowned for her expertise in breast cancer and innovative research, she combines clinical excellence with a commitment to advancing oncology through cutting-edge trials and education.
Dr Diego Ottaviani is a Medical Oncologist at University College Hospital (UCLH), with a specialist focus on breast cancer, immunotherapy, and the treatment of brain metastases. Dedicated to advancing patient care through cutting-edge treatments and translational research, he combines clinical excellence with a passion for innovation in oncology.
Our virtual second opinion service is led by experienced consultant oncologists and provides a thorough, independent review of your cancer diagnosis and treatment plan. The process is simple and secure:
Choose a convenient time for your video consultation. No referral needed. Usually available within 48 hours.
Submit the key documents: pathology reports, radiology reports, clinical letters, and any recent test results.
Your consultant oncologist will discuss your diagnosis, answer your questions, and provide a clear expert opinion on your treatment options.
After your consultation, you’ll receive a detailed summary letter outlining everything discussed, along with our recommendations and suggested next steps.
The consultation provides an independent specialist review of your breast cancer diagnosis, pathology, imaging reports, previous treatments, and current treatment recommendations. The focus is on systemic treatment options, including chemotherapy, endocrine therapy, targeted therapies, immunotherapy, and clinical trial options where appropriate.
The service focuses specifically on systemic treatment for breast cancer. This includes advice on chemotherapy, endocrine (hormonal) therapy, targeted therapies, immunotherapy, treatment sequencing, and clinical trial options. Recommendations are tailored to the biology of the cancer, previous treatments, overall health, and individual treatment goals.
The service does not provide specialist advice on breast surgery techniques or radiotherapy planning. These areas are managed by breast surgeons and clinical oncologists respectively.
The service is provided exclusively through secure video consultations. This allows patients to access specialist second-opinion advice remotely from anywhere in the UK or internationally.
Patients may seek a second opinion at any stage of breast cancer treatment. Common reasons include confirming a treatment recommendation, exploring additional treatment options, discussing targeted therapies or immunotherapy, understanding clinical trial opportunities, reviewing treatment options for metastatic breast cancer, or seeking greater clarity before making treatment decisions.
Patients are usually asked to provide pathology reports, imaging reports, and oncology clinic letters. These documents help ensure a detailed review can take place before the consultation.
Appointments can usually be arranged within 48 hours, depending on availability and receipt of the relevant medical records.
Initial consultations are typically 50 minutes. This allows time for a detailed discussion of diagnosis, previous treatments, current concerns, and treatment options. Follow-up appointments are usually 25 minutes.
No GP referral is required. Patients are welcome to self-refer directly for a private consultation.
Yes. Advice can include discussion of clinical trial opportunities, immunotherapy, targeted therapies, endocrine treatment strategies, and emerging systemic treatment approaches where appropriate. The suitability of these options depends on the specific characteristics of the cancer and previous treatments received.
Currently consultations are available on a self-pay basis only.
Following the consultation, patients will usually receive a written summary outlining the discussion and treatment considerations. Where appropriate, recommendations can also be shared with the patient’s treating medical team.
We’d be delighted to hear from you with any questions. Please complete the form or contact us.